Ind-Swift Laboratories Limited has reported Consolidated financial results for the period ended March 31, 2022.
Financial Results (Q4 FY2022) - QoQ Comparison
The company has reported total income of Rs. 327.8591 crores during the period ended March 31, 2022 as compared to Rs. 255.0467 crores during the period ended December 31, 2021.
The company has posted net profit / (loss) of Rs. -61.4532 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs. 16.0295 crores for the period ended December 31, 2021.
The company has reported EPS of Rs. -10.40 for the period ended March 31, 2022 as compared to Rs. 2.71 for the period ended December 31, 2021.
Total Income | ₹ 327.8591 crs | ₹255.0467 crs | 28.55% |
Net Profit | ₹-61.4532 crs | ₹16.0295 crs | -483.38% |
EPS | ₹-10.40 | ₹2.71 | -483.76% |
Financial Results (Q4 FY2022) - YoY Comparison The company has reported total income of Rs. 327.8591 crores during the period ended March 31, 2022 as compared to Rs.229.1114 crores during the period ended March 31, 2021.
The company has posted net profit / (loss) of Rs.-61.4532 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs.-29.1897 crores for the period ended March 31, 2021.
The company has reported EPS of Rs.-10.40 for the period ended March 31, 2022 as compared to Rs.-4.94 for the period ended March 31, 2021.
Total Income | ₹ 327.8591 crs | ₹229.1114 crs | 43.10% |
Net Profit | ₹-61.4532 crs | ₹-29.1897 crs | 110.53% |
EPS | ₹-10.40 | ₹-4.94 | 110.53% |
Financial Results (Year Ended FY2022) - YoY Comparison The company has reported total income of Rs.1081.4479 crores during the Financial Year ended March 31, 2022 as compared to Rs.914.0419 crores during the Financial Year ended March 31, 2021.
The company has posted net profit / (loss) of Rs.-2.1490 crores for the Financial Year ended March 31, 2022 as against net profit / (loss) of Rs.-3.1472 crores for the Financial Year ended March 31, 2021.
The company has reported EPS of Rs.-0.36 for the Financial Year ended March 31, 2022 as compared to Rs.-0.53 for the Financial Year ended March 31, 2021.
Total Income | ₹1081.4479 crs | ₹914.0419 crs | 18.31% |
Net Profit | ₹-2.1490 crs | ₹-3.1472 crs | 31.72% |
EPS | ₹-0.36 | ₹-0.53 | 32.08% |
Shares of Ind-Swift Laboratories Limited was last trading in BSE at Rs. 58.45 as compared to the previous close of Rs. 57.10. The total number of shares traded during the day was 1385 in over 102 trades.
The stock hit an intraday high of Rs. 59.15 and intraday low of 58.30. The net turnover during the day was Rs. 81298.00.
Source : Equity Bulls
Keywords
IndSwiftLaboratories
Q4FY22
FY2022
ResultUpdate